NCT00392353 2026-04-13
Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia
National Cancer Institute (NCI)
Phase 1/2 Active not recruiting
National Cancer Institute (NCI)
Taiho Oncology, Inc.
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Apollo Therapeutics Ltd